Alliance for Clinical Trials in Oncology

Clinical Trials

Browse or search Alliance’s portfolio of active and completed trials in oncology. Visit ClinicalTrials.gov for contact information, full trial details, eligibility criteria, and how to enroll.

Search by keyword, trial ID, or study chair

Disease/Cancer Type

Alliance Committee

Status

Trial Type

Alliance Committee
Trial Title
Study ID
Disease/Cancer Type
Status
Study Chair Name
Experimental Therapeutics
Irinotecan in Treating Aging Patients With Solid Tumors
NCT00026195
Solid Tumors
Closed
Stuart M. Lichtman, MD
Breast Cancer
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
NCT01086605
Breast Cancer
Closed
Alvaro Moreno-Asptia, MD
Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer
NCT00005059
Lung Cancer & Mesothelioma
Closed
Aminah Jatoi, MD
Breast Cancer
Biomarkers in Tissue Samples From Older Women With Breast Cancer
NCT01346579
Breast Cancer
Closed
Mary Ellen Moynahan, MD
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00006012
Lung Cancer & Mesothelioma
Closed
Scott Okuno, MD
Cancer Control
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
NCT01905046
Breast Cancer
Open
Victoria Seewaldt, MD
Respiratory Cancer
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
NCT00126581
Lung Cancer & Mesothelioma
Closed
Pasi A Janne
Respiratory Cancer
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
NCT05798663
Lung Cancer & Mesothelioma
Open
Helen Ross, MD
Respiratory Cancer
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
NCT01085630
Lung Cancer & Mesothelioma
Closed
Arkadiusz Dudek, MD
Neuro-Oncology
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
NCT07215910
Brain / Central Nervous System Cancer
Open
Ugonma N. Chukwueke, MD; Rifaquat M. Rahman, MD; Patrick Y. Wen, MD

Research in Action

See how Alliance trials are advancing treatment

Alliance News